133 related articles for article (PubMed ID: 9255754)
1. Effect of tibolone on postmenopausal women with myomas.
Gregoriou O; Vitoratos N; Papadias C; Konidaris S; Costomenos D; Chryssikopoulos A
Maturitas; 1997 Jun; 27(2):187-91. PubMed ID: 9255754
[TBL] [Abstract][Full Text] [Related]
2. Long term effects of Tibolone on postmenopausal women with uterine myomas.
Gregoriou O; Konidaris S; Botsis D; Papadias C; Makrakis E; Creatsas G
Maturitas; 2001 Oct; 40(1):95-9. PubMed ID: 11684378
[TBL] [Abstract][Full Text] [Related]
3. Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT.
de Aloysio D; Altieri P; Penacchioni P; Salgarello M; Ventura V
Maturitas; 1998 Jun; 29(3):261-4. PubMed ID: 9699198
[TBL] [Abstract][Full Text] [Related]
4. A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
Fedele L; Bianchi S; Raffaelli R; Zanconato G
Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):91-4. PubMed ID: 10659924
[TBL] [Abstract][Full Text] [Related]
5. Cause of vaginal bleeding in postmenopausal women taking tibolone.
Ginsburg J; Prelevic GM
Maturitas; 1996 May; 24(1-2):107-10. PubMed ID: 8794441
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
Hänggi W; Bersinger N; Altermatt HJ; Birkhäuser MH
Maturitas; 1997 Jun; 27(2):133-43. PubMed ID: 9255748
[TBL] [Abstract][Full Text] [Related]
7. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Menopause; 1999; 6(4):299-306. PubMed ID: 10614676
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.
Moro E; Degli Esposti E; Borghese G; Manzara F; Zanello M; Raimondo D; Gava G; Arena A; Casadio P; Meriggiola MC; Seracchioli R
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480288
[No Abstract] [Full Text] [Related]
9. [The influence of a tibolone therapy on endometrium in postmenopausal women].
Szlendak-Sauer K; Wierzba W; Radowicki S
Ginekol Pol; 2008 Nov; 79(11):758-61. PubMed ID: 19140498
[TBL] [Abstract][Full Text] [Related]
10. [The effects of menopausal replacement therapy in women with uterine myomas].
Orsini G; Pinto V; Di Biase S; D'Altorio C; Lanzilotti G
Minerva Ginecol; 1999 Nov; 51(11):421-5. PubMed ID: 10726441
[TBL] [Abstract][Full Text] [Related]
11. Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
Simsek T; Karakus C; Trak B
Maturitas; 2002 Jul; 42(3):243-6. PubMed ID: 12161049
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of tibolone on the endometrium as assessed by bleeding episodes, transvaginal scan and endometrial biopsy.
Bruce D; Robinson J; Rymer J
Climacteric; 2004 Sep; 7(3):261-6. PubMed ID: 15669550
[TBL] [Abstract][Full Text] [Related]
13. Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study.
Yang CH; Lee JN; Hsu SC; Kuo CH; Tsai EM
Maturitas; 2002 Sep; 43(1):35-9. PubMed ID: 12270580
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: a transvaginal color Doppler study.
Botsis D; Kassanos D; Kalogirou D; Antoniou G; Karakitsos P; Zourlas PA
Maturitas; 1997 May; 27(1):77-83. PubMed ID: 9158081
[TBL] [Abstract][Full Text] [Related]
15. Short and long term effects of tibolone in postmenopausal women.
Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
[TBL] [Abstract][Full Text] [Related]
16. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
17. Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women.
Genazzani AD; Gamba O; Nappi L; Volpe A; Petraglia F
Maturitas; 1997 Sep; 28(1):27-33. PubMed ID: 9391992
[TBL] [Abstract][Full Text] [Related]
18. Effects of tibolone on the breast.
Colacurci N; Mele D; De Franciscis P; Costa V; Fortunato N; De Seta L
Eur J Obstet Gynecol Reprod Biol; 1998 Oct; 80(2):235-8. PubMed ID: 9846676
[TBL] [Abstract][Full Text] [Related]
19. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
[TBL] [Abstract][Full Text] [Related]
20. Long term effects of tibolone on the genital tract in postmenopausal women.
Morris EP; Wilson PO; Robinson J; Rymer JM
Br J Obstet Gynaecol; 1999 Sep; 106(9):954-9. PubMed ID: 10492108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
